These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33536537)

  • 1. Iron accumulation in the oculomotor nerve of the progressive supranuclear palsy brain.
    Lee H; Lee MJ; Kim EJ; Huh GY; Lee JH; Cho H
    Sci Rep; 2021 Feb; 11(1):2950. PubMed ID: 33536537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy.
    Han YH; Lee JH; Kang BM; Mun CW; Baik SK; Shin YI; Park KH
    J Neurol Sci; 2013 Feb; 325(1-2):29-35. PubMed ID: 23260321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive supranuclear palsy: high-field-strength MR microscopy in the human substantia nigra and globus pallidus.
    Foroutan P; Murray ME; Fujioka S; Schweitzer KJ; Dickson DW; Wszolek ZK; Grant SC
    Radiology; 2013 Jan; 266(1):280-8. PubMed ID: 23151826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated volumetric determination of high R
    Tessema AW; Lee H; Gong Y; Cho H; Adem HM; Lyu I; Lee JH; Cho H
    NMR Biomed; 2022 Nov; 35(11):e4795. PubMed ID: 35775868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative susceptibility mapping in atypical Parkinsonisms.
    Mazzucchi S; Frosini D; Costagli M; Del Prete E; Donatelli G; Cecchi P; Migaleddu G; Bonuccelli U; Ceravolo R; Cosottini M
    Neuroimage Clin; 2019; 24():101999. PubMed ID: 31539801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease.
    Massey LA; Miranda MA; Al-Helli O; Parkes HG; Thornton JS; So PW; White MJ; Mancini L; Strand C; Holton J; Lees AJ; Revesz T; Yousry TA
    Neuroimage Clin; 2017; 13():154-163. PubMed ID: 27981030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism.
    Sjöström H; Surova Y; Nilsson M; Granberg T; Westman E; van Westen D; Svenningsson P; Hansson O
    Sci Rep; 2019 Apr; 9(1):6079. PubMed ID: 30988382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative susceptibility mapping differentiates between parkinsonian disorders.
    Sjöström H; Granberg T; Westman E; Svenningsson P
    Parkinsonism Relat Disord; 2017 Nov; 44():51-57. PubMed ID: 28886909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
    An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
    J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining quantitative susceptibility mapping to the morphometric index in differentiating between progressive supranuclear palsy and Parkinson's disease.
    Azuma M; Hirai T; Nakaura T; Kitajima M; Yamashita S; Hashimoto M; Yamada K; Uetani H; Yamashita Y; Wang Y
    J Neurol Sci; 2019 Nov; 406():116443. PubMed ID: 31634718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain regional iron contents in progressive supranuclear palsy.
    Lee SH; Lyoo CH; Ahn SJ; Rinne JO; Lee MS
    Parkinsonism Relat Disord; 2017 Dec; 45():28-32. PubMed ID: 28982612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Effect of Iron and Myelin on Susceptibility MRI in the Substantia Nigra.
    Lee H; Cho H; Lee MJ; Kim TH; Roh J; Lee JH
    Radiology; 2021 Dec; 301(3):682-691. PubMed ID: 34609198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative MRI and laser ablation-inductively coupled plasma-mass spectrometry imaging of iron in the frontal cortex of healthy controls and Alzheimer's disease patients.
    Bulk M; Abdelmoula WM; Geut H; Wiarda W; Ronen I; Dijkstra J; van der Weerd L
    Neuroimage; 2020 Jul; 215():116808. PubMed ID: 32289451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and diagnostic potential of R
    Beliveau V; Müller C; Steiger R; Gizewski ER; Poewe W; Seppi K; Scherfler C
    Parkinsonism Relat Disord; 2022 Aug; 101():43-48. PubMed ID: 35792337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential usefulness of signal intensity of cerebral gyri on quantitative susceptibility mapping for discriminating corticobasal degeneration from progressive supranuclear palsy and Parkinson's disease.
    Miyata M; Kakeda S; Toyoshima Y; Ide S; Okada K; Adachi H; Wang Y; Korogi Y
    Neuroradiology; 2019 Nov; 61(11):1251-1259. PubMed ID: 31267152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substantia nigra echogenicity in progressive supranuclear palsy.
    Ebentheuer J; Canelo M; Trautmann E; Trenkwalder C
    Mov Disord; 2010 Apr; 25(6):773-7. PubMed ID: 20198715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Swallow tail sign on susceptibility map-weighted imaging (SMWI) for disease diagnosing and severity evaluating in parkinsonism.
    Liu X; Wang N; Chen C; Wu PY; Piao S; Geng D; Li Y
    Acta Radiol; 2021 Feb; 62(2):234-242. PubMed ID: 32380911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of substantia nigra hyperintensity on 7 Tesla MRI of Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Kim JM; Jeong HJ; Bae YJ; Park SY; Kim E; Kang SY; Oh ES; Kim KJ; Jeon B; Kim SE; Cho ZH; Kim YB
    Parkinsonism Relat Disord; 2016 May; 26():47-54. PubMed ID: 26951846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI.
    Ahmadi SA; Bötzel K; Levin J; Maiostre J; Klein T; Wein W; Rozanski V; Dietrich O; Ertl-Wagner B; Navab N; Plate A
    Neuroimage Clin; 2020; 26():102185. PubMed ID: 32050136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders.
    Zhang P; Chen J; Cai T; He C; Li Y; Li X; Chen Z; Wang L; Zhang Y
    Front Aging Neurosci; 2022; 14():909552. PubMed ID: 35992605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.